Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aromatase inhibitors: future directions.

C Kent Osborne1, Rachel Schiff

  • 1Breast Center, Baylor College of Medicine and The Methodist Hospital, One Baylor Plaza, BCM 600, Houston, TX 77030, USA. kosborne@breastcenter.tmc.edu

The Journal of Steroid Biochemistry and Molecular Biology
|July 16, 2005
PubMed
Summary

Aromatase inhibitors are effective endocrine therapy for postmenopausal breast cancer by blocking estrogen production. Further research is needed on long-term toxicity and optimal duration for breast cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rat somatic genome editing enables ER+ breast cancer modeling.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Script-Specific Predictors of Reading Comprehension in Hebrew-Speaking Children With Reading Difficulties.

Dyslexia (Chichester, England)·2026
Same author

Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancer.

Molecular cancer research : MCR·2026
Same author

The dynamics of RAN and cognitive-linguistic skills in vowelized and unvowelized Hebrew word reading among children with reading difficulties.

Annals of dyslexia·2026
Same author

JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6.

NPJ breast cancer·2026
Same author

What Predicts Listening Comprehension in Standard Arabic? The Interdependence of Linguistic and Metalinguistic Skills in Spoken and Standard Arabic.

Journal of speech, language, and hearing research : JSLHR·2025

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Estrogen and estrogen receptors are crucial in breast cancer development and progression.
  • Aromatase inhibitors effectively reduce estrogen levels in postmenopausal women.
  • These inhibitors are a primary endocrine therapy for metastatic breast cancer.

Purpose of the Study:

  • To review the role of aromatase inhibitors in breast cancer therapy.
  • To explore the mechanisms underlying aromatase inhibitor effectiveness.
  • To identify strategies for overcoming resistance to endocrine therapies.

Main Methods:

  • Review of experimental studies and clinical observations on estrogen receptor activity.
  • Analysis of aromatase inhibitor efficacy in postmenopausal breast cancer.

Related Experiment Videos

  • Investigation of estrogen receptor signaling pathways and crosstalk with growth factors.

    • Main Results:

    • Aromatase inhibitors are the leading endocrine therapy for metastatic breast cancer in postmenopausal women.
    • These agents are likely to become standard adjuvant therapy.
    • Blocking both genomic and non-genomic estrogen receptor activities is vital for optimal endocrine therapy effectiveness.

    Conclusions:

    • Aromatase inhibitors demonstrate excellent performance in breast cancer treatment.
    • Understanding estrogen receptor signaling and its crosstalk with growth factors explains their efficacy.
    • Targeting growth factor receptors may prevent or delay resistance to aromatase inhibitors and other endocrine therapies.